Return to program book search
Genetics and Genetic Testing: Beyond Mendel
Friday, March 21
10:00 AM - 12:00 PM
Sharon A. Glick, MD, FAAD
- Keith Choate, MD, PhD, FAAD
- Daniela Kroshinsky, MD, MPH, FAAD
- Sancy A. Leachman, MD, PhD, FAAD
- Anne W. Lucky, MD, FAAD
Following this course, the attendee should be able to:
- Identify when genodermatoses and melanoma should be referred for genetic testing.
- Recognize recently described entities associated with exome sequencing.
- Utilize prenatal and preimplantation genetic diagnosis options when caring for families with genetic skin disease.
This session will provide attendees with updates on genetic testing for the genodermatoses, including epidermolysis bullosa and the ichthyoses, and on melanoma. Exome sequencing is a powerful new cost-effective method for identifying genes previously unidentifiable using conventional genetic studies. The role of the exome in identification of new mutations in old genes will be discussed. Prenatal and preimplantation genetic diagnosis and direct-to-consumer genetic testing will be reviewed. This session is directed at practicing dermatologists and those in training.
|Friday, March 21|
|10:00 AM||Genetic Testing and the Genodermatoses / Dr. Glick|
|10:20 AM||Exome Sequencing: New Mutations in Old Genes / Dr. Choate|
|10:40 AM||Genetics and Genetic Testing of Epidermolysis Bullosa / Dr. Lucky|
|11:00 AM||Update on Prenatal and Preimplantation Genetic Diagnosis / Dr. Kroshinsky|
|11:20 AM||Q and A / Dr. Glick, Dr. Lucky, Dr. Kroshinsky, and Dr. Choate|
|11:30 AM||Genetic Testing for Melanoma / Dr. Leachman|
|11:45 AM||Update on Direct-to-Consumer Genetic Testing / Dr. Leachman|
|11:55 AM||Q and A / Dr. Leachman|